Evidence map›Paper›PMID 34383485›Full record

ArticleACS nano2021

From NiMoO

Robin N Dürr, Pierfrancesco Maltoni, Haining Tian, Bruno Jousselme, Leif Hammarström, Tomas Edvinsson

Erratum issuedAbstract read
In one paragraph

Article in ACS nano, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Compositional Engineering of TiACS applied energy materials · 2025
    Article
  8. Article
  9. Molybdate-Modified NiOOH for Efficient Methanol-Assisted Seawater Electrolysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  10. Article
  11. Article
  12. Enhanced Oxygen Evolution Reaction Performance of NiMoOLangmuir : the ACS journal of surfaces and colloids · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Oxygen-Plasma-Induced Hetero-Interface NiFeMaterials (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Robin N DürrDepartment of Chemistry, Physical Chemistry, Ångström Laboratory, Uppsala University, Box 523, 751 20 Uppsala, Sweden.ORCID 0000-0002-8696-0496
Pierfrancesco MaltoniDepartment of Materials Science and Engineering, Solid State Physics, Ångström Laboratory, Uppsala University, Box 35, 751 03 Uppsala, Sweden.ORCID 0000-0001-9834-3164
Haining TianDepartment of Chemistry, Physical Chemistry, Ångström Laboratory, Uppsala University, Box 523, 751 20 Uppsala, Sweden.ORCID 0000-0001-6897-2808
Bruno JousselmeUniversité Paris-Saclay, CEA, CNRS, NIMBE, LICSEN, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-4964-5120
Leif HammarströmDepartment of Chemistry, Physical Chemistry, Ångström Laboratory, Uppsala University, Box 523, 751 20 Uppsala, Sweden.ORCID 0000-0002-9933-9084
Tomas EdvinssonDepartment of Materials Science and Engineering, Solid State Physics, Ångström Laboratory, Uppsala University, Box 35, 751 03 Uppsala, Sweden.ORCID 0000-0003-2759-7356

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Water electrolysis powered by renewable energies is a promising technology to produce sustainable fossil free fuels. The development and evaluation of effective catalysts are here imperative; however, due to the inclusion of elements with different redox properties and reactivity, these materials undergo dynamical changes and phase transformations during the reaction conditions. NiMoO

Indexed as

alkaline water splittingelectrocatalysisin situ catalyst formationmolybdenum leachingnanostructuresnickel molybdatetime-resolved operando Raman spectroscopy

Identifiers

PMID34383485
PMCPMC8388116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.